/Prostate Cancer Nuclear Medicine Diagnostics Market Expected to Witness High Growth over the Forecast to 2027- Theradiagnostics Ltd, Curium Pharma, Novartis AG (Endocyte)
Prostate Cancer Nuclear Medicine Diagnostics Market Expected to Witness High Growth over the Forecast to 2027- Theradiagnostics Ltd, Curium Pharma, Novartis AG (Endocyte)
Prostate Cancer Nuclear Medicine Diagnostics Market Forecast to 2027- Covid-19 Impact and Global Analysis - by Type; PET Product , and Geography
tipFebruary 19, 2021
“
Prostate cancer is cancer affecting the prostate glands in men. Prostate cancer is the second most common cancer after skin cancer in men. Several common factors accountable for the onset of prostate cancer are old age, family history, and race. Nuclear medicine is imaging that requires radioactive materials. It is a useful method to detect and also treat prostate cancer and helps radiologists to conclude the stage of cancer.”